Showing results (581-590 of 1,813) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|May 22, 2022
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple MyelomaScott R Solomon, Stacey Brown, Nancy Shegda, et al.
Transplantation and Cellular Therapy|May 23, 2022
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple MyelomaAimaz Afrough, Leonard C Alsfeld, Denái R Milton, et al.
Transplantation and Cellular Therapy|May 24, 2022
Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?Li-Fang Huang, Li Li, Jin-Song Jia, et al.
Transplantation and Cellular Therapy|June 12, 2022
Synthetic Immunotherapy: Programming Immune Cells with Novel and Sophisticated Logic CapabilitiesCalvin K Lam, R Katherine Hyde, Sachit A Patel
Transplantation and Cellular Therapy|June 19, 2022
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation SurvivorsTanya Lehky, Iago Pinal Fernandez, Elizabeth F Krakow, et al.
Transplantation and Cellular Therapy|July 7, 2022
Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort StudyNeel S Bhatt, Akshay Sharma, Andrew St Martin, et al.
Transplantation and Cellular Therapy|June 28, 2022
Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell TransplantationJoshua A Hill, Seung Hyun Moon, Aastha Chandak, et al.
Transplantation and Cellular Therapy|May 30, 2021
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-AnalysisJan Philipp Bewersdorf, Amar H Sheth, Shaurey Vetsa, et al.
Transplantation and Cellular Therapy|July 5, 2022
Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR LigandScott R Solomon, Michael T Aubrey, Xu Zhang, et al.
Transplantation and Cellular Therapy|June 17, 2022
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationGiorgia Battipaglia, Myriam Labopin, Didier Blaise, et al.
Pageof 182